Rational design of peptides to overcome drug resistance by metabolic regulation
Drug Resistance Updates · 2025
DOI: 10.1016/j.drup.2025.101208 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2025. Verfasst von Min Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Ane…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Peptides, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 197 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Rising-Star Program, University of Sheffield.
Abstract (Originalsprache)
Chemotherapy is widely used clinically, however, its efficacy is often compromised by the development of drug resistance, which arises from prolonged administration of drugs or other stimuli. One of the driven causes of drug resistance in tumors or bacterial infections is metabolic reprogramming, which alters mitochondrial metabolism, disrupts metabolic pathways and causes ion imbalance. Bioactive peptide materials, due to their biocompatibility, diverse bioactivities, customizable sequences, and ease of modification, have shown promise in overcoming drug resistance. This review provides an in-depth analysis of metabolic reprogramming and associated microenvironmental changes that contribute to drug resistance in common tumors and bacterial infections, suggesting potential therapeutic targets. Additionally, we explore peptide-based materials for regulating metabolism and their potential synergic effect with other therapies, highlighting the mechanisms by which these peptides reverse drug resistance. Finally, we discuss future perspectives and the clinical challenges in peptide-based treatments, aiming to offer insights for overcoming drug-resistant diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology and Obstetrics, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institu…
- School of Materials Science and Engineering, East China University of Science and Technology, Shanghai 200237, China.
- Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China.
- College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Förderung
- Science and Technology Commission of Shanghai Municipality
- Shanghai Rising-Star Program
- University of Sheffield
- Shanghai Municipal Education Commission
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Sun, M., He, L., Chen, R., Lv, M., Chen, Z. S., Fan, Z., Zhou, Y., Qin, J., & Du, J. (2025). Rational design of peptides to overcome drug resistance by metabolic regulation. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2025.101208
Vancouver
Sun M, He L, Chen R, Lv M, Chen ZS, Fan Z, et al. Rational design of peptides to overcome drug resistance by metabolic regulation. Drug Resistance Updates. 2025. doi:10.1016/j.drup.2025.101208
BibTeX
@article{Sun2025,
author = {Sun, Min and He, Le and Chen, Ran and Lv, Mingchen and Chen, Zhe-Sheng and Fan, Zhen and Zhou, Yuxiao and Qin, Jinlong and Du, Jianzhong},
title = {Rational design of peptides to overcome drug resistance by metabolic regulation},
journal = {Drug Resistance Updates},
year = {2025},
doi = {10.1016/j.drup.2025.101208}
}
EUVIMED